Updated: FDA approves Autolus’ CAR-T cell therapy for aggressive blood cancernews2024-11-11T08:09:09+00:00November 11th, 2024|Endpoints News|
#ASH24: Gilead and Arcellx spotlight safety of multiple myeloma cell therapy, dose first patient in Phase 3news2024-11-05T16:08:48+00:00November 5th, 2024|Endpoints News|
#ASH24: Beam discloses first clinical data on base-edited sickle cell therapy, one patient deathnews2024-11-05T15:19:56+00:00November 5th, 2024|Endpoints News|
Exclusive: Blood stem cell therapy maker Garuda gets new CEO, adds $47Mnews2024-11-01T12:55:10+00:00November 1st, 2024|Endpoints News|
